Middle East & Africa Idiopathic Thrombocytopenic Purpura Therapeutics Market Size & Outlook

Name: Middle East & Africa Idiopathic Thrombocytopenic Purpura Therapeutics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The idiopathic thrombocytopenic purpura therapeutics market in Middle East & Africa is expected to reach a projected revenue of US$ 38.4 million by 2030. A compound annual growth rate of 5.3% is expected of Middle East & Africa idiopathic thrombocytopenic purpura therapeutics market from 2024 to 2030.

Pharmaceuticals
- Blood Disorders Treatment
  - idiopathic thrombocytopenic purpura itp therapeutics

Middle East & Africa idiopathic thrombocytopenic purpura itp therapeutics disease type outlook (Revenue, USD million, 2018-2030)
- Acute ITP
- Chronic
- Others
Middle East & Africa idiopathic thrombocytopenic purpura itp therapeutics product outlook (Revenue, USD million, 2018-2030)
- Corticosteroids
- IVIG
- Anti-D Immunoglobulins
- TPO-RA
- Others

Middle East & Africa Idiopathic Thrombocytopenic Purpura Therapeutics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!